Uremic Toxins: What Are They? An Integrated Overview of Pathobiology and Classification

Journal of Renal Nutrition

Volumn 18, Issue 1, 2008, Pages 2-6

  Glassock, Richard J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (9 ANTHRYL) 3 (4 DIMETHYLANILINE) PROPANE; 1-(9-ANTHRYL)-3-(4-DIMETHYLANILINE) PROPANE; ANILINE DERIVATIVE; ANTHRACENE DERIVATIVE; DRUG DERIVATIVE; PROPANE; TOXIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; CLASSIFICATION; HUMAN; MOLECULAR WEIGHT; PATHOLOGY; PATHOPHYSIOLOGY; UREMIA;

ANILINE COMPOUNDS; ANTHRACENES; HUMANS; KIDNEY FAILURE, CHRONIC; MOLECULAR WEIGHT; PROPANE; TOXINS, BIOLOGICAL; UREMIA;

EID: 37049004490     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2007.10.003     Document Type: Article

References (15)

1. Vanholder R., De Smet R., Glorieux G., et al. Review on uremic toxins. Classification, concentration and inter-individual variability. Kidney Int 63 (2003) 1934-1943
2. Bergstrom J., and Furst P. Uremic toxins. Kidney Int Suppl (1978) S9-S12
3. Massry S.G. Is parathyroid hormone a uremic toxin?. Nephron 19 (1977) 125-130
4. Merrill J.P., and Hampers C.L. Uremia. Progress in pathophysiology and treatment (1971), Grune and Stratton, New York
5. Niwa T. Indoxyl sulfate. In: Massry S.G., and Glassock R.J. (Eds). Textbook of nephrology. 4th ed. (2001), Lippincott, Williams and Wilkins, Philadelphia 1269-1271
6. Schepers E., Meert N., Gloriex G., Goeman J., Van der Eycken J., and Vanholder R. P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transplant 22 (2007) 592-596
7. Leiper J., Nandi M., Torondel B., et al. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med 13 (2007) 198-203
8. Heinig M., and Johnson R.J. Uric acid in hypertension, renal disease and metabolic syndrome. Cleve Clin J Med 73 (2006) 1059-1064
9. Rutkowski B., Swierczynski J., Slominska E., et al. Disturbances of purine nucleotide metabolism in uremia. Semin Nephrol 24 (2004) 479-483
10. Babb A.L., Farrell P.C., Uvelli D.A., and Scribner B.H. Hemodialyzer evaluation by examination of solute molecular spectra. Trans Am Soc Artif Organs 18 (1972) 98-102
11. Stenvinkel P. Inflammation in end-stage renal disease: the hidden enemy. Nephrology 11 (2006) 36-41
12. Kielstein J.T., and Zocalli C. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age. Am J Kidney Dis 46 (2005) 186-202
13. Cardounel A.J., Cui H., Samouilov A., et al. Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. J Biol Chem 12 (2007) 879-887
14. Jensen W.B. Mendeleev on the periodic law: selected writings, 1869-1905 (2005), Dover, Mineola, NY
15. Mendeleyev D.I., and Jensen W.B. Mendeleev on the periodic law: selected writings, 1899-1905 (2005), Dover, Mineola, NY